Cysteine-scanning Mutagenesis around Transmembrane Segment III of Tn10-encoded Metal-Tetracycline/H+ Antiporter*

Tomomi KimuraDagger , Yasuko Shiina§, Tetsuo Sawai§, and Akihito YamaguchiDagger par

From the Dagger  Department of Cell Membrane Biology, Institute of Scientific and Industrial Research, Osaka University, Mihogaoka, Ibaraki, Osaka 567, Japan, the § Division of Microbial Chemistry, Faculty of Pharmaceutical Sciences, Chiba University, Chiba 263, Japan, and the  Faculty of Pharmaceutical Sciences, Osaka University, Yamadaoka, Suita, Osaka 565, Japan

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Each amino acid in the putative transmembrane helix III and its flanking regions (from Gly-62 to Tyr-98) of the Tn10-encoded metal-tetracycline/H+ antiporter (Tet(B)) was individually replaced with Cys. Out of these 37 cysteine-scanning mutants, the mutants from G62C to R70C and from S92C to Y98C showed high or intermediate reactivity with [14C]N-ethylmaleimide (NEM) except for the M64C mutant. On the other hand, the mutants from R71C to S91C showed almost no reactivity with NEM except for the P72C mutant. These results confirm that the transmembrane helix III is composed of 21 residues from Arg-71 to Ser-91. The majority of Cys replacement mutants retained high or moderate tetracycline transport activity. Cys replacements for Gly-62, Asp-66, Ser-77, Gly-80, and Asp-84 resulted in almost inactive Tet(B) (less than 3% of the wild-type activity). The Arg-70 right-arrow Cys mutant retained very low activity due to a mercaptide between Co2+ and a SH group (Someya, Y., and Yamaguchi, A. (1996) Biochemistry 35, 9385-9391). Three of these six important residues (Ser-77, Gly-80, and Asp-84) are located in the transmembrane helix III and one (Arg-70) is located in the flanking region. These four functionally important residues are located on one side of the helical wheel. Only two of the residual 31 Cys mutants were inactivated by NEM (S65C and L97C). Ser-65 and Leu-97 are located on the cytoplasmic and periplasmic loops, respectively, in the topology of Tet(B). The degree of inactivation of these Cys mutants with SH reagents was dependent on the volume of substituents. In the presence of tetracycline, the reactivity of the S65C mutant with NEM was significantly increased, in contrast, the reactivity of L97C was greatly reduced, indicating that the cytoplasmic and periplasmic loop regions undergo substrate-induced conformational change in the mutually opposite direction.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The transposon Tn10-encoded Tet(B) protein is one of the family of bacterial tetracycline exporters of Gram-negative bacteria that includes Tet(A) to (H) (1). It is a polytopic cytoplasmic membrane protein that catalyzes stoichiometric metal-tetracycline/H+ antiport (2-4). It is composed of 401 amino acid residues (5, 6). Tet(B) belongs to a major facilitator superfamily (7) that includes uniporters and symporters in addition to bacterial multidrug exporters such as NorA (8) and Bmr (9). Most of the major facilitator family transporters are predicted to have a 12-membrane-spanning structure (7). With respect to tetracycline/H+ antiporters, Eckert and Beck (10) and Henderson and Maiden (11) proposed similar 12-membrane-spanning topologies of Tet(B) and pBR322-Tet(C) based on the results of hydropathy analysis. Allard and Bertrand (12) experimentally confirmed the topology of pBR322-Tet(C) by means of alkaline-phosphatase (PhoA) gene fusions. Recently, we experimentally established the 12-membrane-spannning structure of Tet(B) by using the intact protein on the basis of the results of the competitive binding of membrane permeable and impermeable SH reagents to the cysteine residues introduced by site-directed mutagenesis (13).

The cysteine-scanning mutagenesis of lactose permease (14-22) and other membrane transporters (23) has been extensively studied and revealed to be useful for determination of the distribution of functionally essential residues and the arrangement of transmembrane helices (24, 25). We showed that the reactivity of the cysteine-scanning mutants of membrane proteins with NEM1 is useful to determine the range of the transmembrane segments and the exact boundaries between membrane-embedded regions and the loop regions exposed to the aqueous phase (26). We reported the exact range of the transmembrane helix IX and experimentally showed the presence of a short loop composed of three amino acid residues between helices IX and X exposed to the aqueous phase (26).

In this study, we established cysteine-scanning mutants around the putative helix III and its flanking regions. Tet(B) contains a conserved sequence motif, GXXXDRXGRR, in the putative cytoplasmic loop2-3, which is common to the major facilitator superfamily transporters (7). Site-directed mutagenesis studies of Tet(B) suggest that the region containing this motif plays a role as an entrance gate for tetracycline translocation (27). The importance of this motif was also confirmed in alpha -ketoglutarate permease (28) and lactose permease (29). In addition, there is an Asp-84 in the middle of helix III, which is one of three essential transmembrane aspartic acid residues (30). The conserved quartet of residues is located around this region and in helix II, which may be related to the substrate binding (31). Therefore, loop2-3 and the helix III region possibly form a substrate translocation pathway of Tet(B). The results in this study confirm that the reactivity of the cysteine-scanning mutants with SH reagents is very useful for determining the boundary between the transmembrane region and the region exposed to the aqueous phase.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials-- N-[1-14C]ethylmaleimide ([14C]NEM) (1.5 GBq/mmol) and [7-3H]tetracycline were purchased from NEN Life Science Products. [alpha -32P]dCTP was purchased from Amersham Corp. All other materials were of reagent grade and obtained from commercial sources.

Site-directed Mutagenesis-- Cysteine-scanning mutants were constructed by oligonucleotide-directed site-specific mutagenesis according to the method of Kunkel (32). For the mutagenesis, plasmid pCT1183 (33) was used as a template that carries the 2.45-kilobase Tn10 tetA(B) and tetR gene fragments. Mutations were detected based on the appearance of a newly introduced restriction site and then verified by DNA sequencing.

Low copy number mutant plasmids were constructed through exchange of the EcoRV-EcoRI fragment of the cysteine-scanning mutant tetA(B) genes with the corresponding fragment of the low copy number plasmid, pLGT2 (30), and used for determination of the reactivity with [14C]NEM.

Assay of the Reaction of [14C]NEM with Tet(B) Proteins-- Sonicated membranes were prepared from Escherichia coli W3104 carrying pLGT2 or its derivatives as described previously (34) except that the cells were disrupted by brief sonication. The reaction of [14C]NEM with Tet(B) proteins in the sonicated membranes were performed as described previously (34). After solubilization, the [14C]NEM-bound Tet(B) proteins were immunoprecipitated with anti-Tet(B) C-terminal peptide antiserum (35) and Pansorbin Staphylococcus aureus cells (36). The resultant pellet was subjected to SDS-polyacrylamide gel electrophoresis, followed by Coomassie Brilliant Blue staining. The resultant gels were soaked in Amplify prior to drying. The dried gels were exposed to an imaging plate for visualization using a BAS-1000 Bio-Imaging Analyzer (Fuji Film Co., Tokyo).

Assay of Tetracycline Transport by Everted Membrane Vesicles-- Everted membrane vesicles were prepared from E. coli TG1 cells carrying a high copy number plasmid pCT1183 or its derivatives as described previously (37). [3H]Tetracycline uptake by everted membrane vesicles was assayed in the presence of 10 µM [3H]tetracycline and 50 µM CoCl2 in 50 mM MOPS-KOH buffer (pH 7.0) containing 0.1 M KCl as described in our previous paper (30).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Construction of Cysteine-scanning Mutants-- Each amino acid in the putative transmembrane helix III and its flanking regions (from Gly-62 to Tyr-98) (Fig. 1) was individually replaced with Cys by site-directed mutagenesis as described under "Experimental Procedures" using the mutagenic primers. Mutants from P72C to Y98C were constructed in this study, whereas those from G62C to R71C were constructed previously (27, 34, 38, 39). Membranes were prepared by brief sonication from E. coli W3104/pLGT2 after induction of tetA(B) gene expression. Resulting membranes were solubilized in 1% Triton X-100 and 0.1% SDS, and then Tet(B) proteins were precipitated with C terminus-specific antiserum (35). After SDS-gel electrophoresis, Tet(B) proteins were detected by Coomassie Brilliant Blue staining (Fig. 2A). There was no significant alteration observed in the level of expression of the Cys-scanning mutants.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 1.   The topology of the putative transmembrane helix III and its flanking loop regions of Tn10-Tet(B). A, predicted by hydropathy analysis (10). B, revised topology based on the results of this study. The positions at which the cysteine mutants showed high reactivity with NEM are indicated by closed circles or squares. Moderately reactive positions are indicated by gray circles or squares. The positions at which the cysteine mutants showed loss of or greatly reduced tetracycline transport activity are enclosed by squares. Arrowheads indicate the positions of the cysteine mutants sensitive to NEM inactivation.


View larger version (67K):
[in this window]
[in a new window]
 
Fig. 2.   The binding of [14C]NEM to the cysteine-scanning mutants of Tn10-Tet(B). The sonicated membranes (0.5 mg of protein) of cysteine-scanning mutants were incubated with 0.5 mM [14C]NEM for 5 min at 30 °C, followed by solubilization and immunoprecipitation of Tet(B) proteins as described under "Experimental Procedures." A, after SDS-PAGE, the protein bands and the radioactive bands were visualized by Coomassie Brilliant Blue staining (upper panels) and by use of a Bio-Imaging Analyzer BAS-1000 (lower panels), respectively. B, relative amount of bound [14C]NEM per Tet(B) protein calculated from band densities in panel A.

Reactivity of the Cys-Scanning Mutants with [14C]NEM-- The [14C]NEM binding to the Cys-scanning mutants is shown in Fig. 2. The result is a typical one out of at least three independent experiments. Since the density of the radioactive bands of the mutant proteins was increased in proportion to the incubation time with [14C]NEM, at least up to 10 min (data not shown), and wild-type Tet(B) did not show any radioactive band, the density reflects the reactivity of each Cys residue introduced in Tet(B). As shown in Fig. 2, Cys residues introduced into positions 62, 63, from 65 to 69, from 92 to 94, and 97 were highly reactive with NEM, and those introduced into positions 70, 72, 95, 96, and 98 showed moderate reactivity, indicating that the former residues are exposed to the aqueous phase and the latter ones are partially exposed. In contrast, Cys residues introduced into positions 64, 71, and from 73 to 91 showed almost no significant reactivity with NEM, indicating that these residues are embedded in the hydrophobic interior. As judged by these observations, the transmembrane helix III is likely to range from Arg-71 to Ser-91. Out of nine residues of the putative cytoplasmic loop2-3, only Met-64 is very slightly reactive with NEM as reported in our previous paper (27, 40), probably due to the fact that the side chain of this position is oriented to the protein interior. On the other hand, there was no moderately reactive position in the mid-transmembrane helix region.

Tetracycline Transport Activity of the Cys-scanning Mutants-- The initial rate (for a period of 30 s) of the tetracycline uptake by everted membrane vesicles containing each Cys-scanning mutant was measured (Fig. 3). The majority of the Cys-scanning mutants exhibited high or moderate tetracycline transport activity (>25% of the wild-type). Only three mutants (D66C, G80C, and D84C) exhibited complete loss of the activity. Two mutants (G62C and S77C) exhibited greatly reduced activity (less than 3% of the wild-type). Another one mutant (R70C) showed significant activity (about 8% of the wild-type); however, since other Arg-70 mutants, except for R70K and R70C, showed no activity (39), Arg-70 is also a functionally important residue. As reported previously, the residual activity of the R70C mutant is due to the mercaptide formed between Co2+ and the SH group acting as a functional positive charge (39). Thus, out of 37 residues of helix III and its flanking regions, only six residues are important for tetracycline transport. The importance and the possible roles of these six residues have been investigated in detail in our previous studies (27, 30, 31, 41). The new finding in this work is that there is no additional essential residue in this region. As shown in Fig. 4, the functionally important residues cluster on one side of helix III in a helical wheel plot, probably supporting the presence of the substrate translocation pathway along this face of helix III.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 3.   Tetracycline transport activity of cysteine-scanning mutants of Tet(B). Initial rate of tetracycline uptake by everted membrane vesicles containing cysteine-scanning mutants was measured for 30 s in the presence of 10 µM [3H]tetracycline and 50 µM CoCl2 as described under "Experimental Procedures."


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   Helical wheel projection of residues in the N-terminal half of the putative helix III. Residues of Cys mutants that showed greatly reduced activity are highlighted by a dark background.

Effect of NEM on Tetracycline Transport Activity-- The initial rate of tetracycline uptake by each vesicle after 5 min of treatment with 2 mM NEM is indicated as a percentage of that in the absence of NEM (Fig. 5). Fig. 5 shows the results for 31 Cys-scanning mutants that showed significant tetracycline transport activity in the absence of NEM. Out of these mutants, the transport activities of only two (S65C and L97C) were greatly inactivated by NEM. On the other hand, the activities of the other 29 Cys mutants were hardly affected by NEM. Although the K63C, R67C to G69C, and S92C to L94C mutants were highly reactive with NEM and the P72C, W95C, M96C, and Y98C mutants were moderately reactive as shown in Fig. 2, the tetracycline transport activities of all these mutants were not inhibited by NEM. This result indicates that positions 65 and 97 are unique hot spots for chemical modification.


View larger version (68K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of NEM on tetracycline transport by everted membrane vesicles containing cysteine-scanning mutants of Tet(B). Everted membrane vesicles were treated with 2 mM NEM for 5 min at 30 °C prior to the tetracycline transport assay. The initial rate of [3H]tetracycline transport was measured as described under "Experimental Procedures." Residual activities are presented as a percentage of the initial rate measured in the absence of NEM.

Fig. 6 shows the dependence of inactivation of the transport activity of the S65C and L97C mutants on the concentration of SH reagents. As reported in our previous paper (37, 40, 42), the transport activity of the S65C mutant was completely inactivated by NEM at less than 1 mM, whereas the inactivation of the activity of the S65C mutant with methyl methanethiosulfonate (MMTS), which substitutes a small thiomethyl group, was saturated at the level of 40%. Since the activity of the MMTS-pretreated S65C mutant was no longer inactivated by NEM, it is clear that each molecule of the thiomethylated S65C mutant retains 60% activity (Fig. 6A). In the case of the L97C mutant, the maximum inactivation level by NEM was about 90%, which was reached at 2 mM NEM (Fig. 6B). MMTS did not affect the tetracycline transport activity of the L97C mutant. The activity of the MMTS-treated L97C mutant was also not inactivated by NEM, indicating that the thiomethylated L97C mutant molecule retains full activity. Such substituent-volume dependence of the inactivation level of the activity of the S65C and L97C mutants with SH reagents indicates that the inactivation is based on the steric hindrance caused by a bulky substituent.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 6.   Dose dependence of inactivation of the S65C and L97C mutants with NEM and MMTS. Everted membrane vesicles were preincubated with the indicated concentrations of NEM (closed circles) or MMTS (open circles) for 5 min at 30 °C prior to the tetracycline transport assay. In the case of sequential treatment (open squares), everted membrane vesicles were first pretreated with 2 mM MMTS for 5 min, and then the incubation was continued in the presence of indicated concentrations of NEM for 5 min. The initial rate of tetracycline transport was measured for 30 s as described under "Experimental Procedures." Residual activity is presented as a percentage of the initial rate in the absence of SH reagents. A, S65C mutant cited from our previous paper (43). B, L97C mutant.

The Effect of Tetracycline on Reactivity of the Hot Spot Mutants with NEM-- The substituent-volume dependence of inactivation of the activity of the S65C and L97C mutants with NEM suggests that these residues are located in the substrate translocation pathway. Thus, the effect of tetracycline on the reactivity of these mutants with [14C]NEM was investigated. Tetracycline significantly stimulates the reactivity of the S65C mutant with NEM as reported previously (43). In contrast, the reactivity of the L97C mutant with NEM was greatly inhibited by tetracycline (Fig. 7), indicating that the degree of exposure of the side chain at position 97 is reduced by the substrate-induced conformational change. When a D66A mutation was added to the L97C mutant, the substrate-induced change in the reactivity with NEM disappeared. On the other hand, the L97C/R70A double mutants retained the substrate-induced conformational change (Fig. 7). This results indicate that Asp-66 confers to the substrate-induced conformational change while Arg-70 may contribute to the step after the conformational change.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of tetracycline on the [14C]NEM binding to the L97C mutant. Everted membrane vesicles of the L97C single mutant or the L97C/D66A or L97C/R70A double mutants were incubated with 0.5 mM [14C]NEM in the absence or presence of 1 mM tetracycline and 5 mM MgCl2 at 30 °C for 5 min. The radioactive bands were detected as described under "Experimental Procedures." - and + indicate the absence and presence of tetracycline, respectively.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The results presented here confirm that the membrane-embedded regions and the aqueous phase-exposed regions can be distinguished on the basis of the reactivity of the cysteine-scanning mutants with NEM as reported previously (26). Out of 37 cysteine-scanning mutants established in this study, the 21 mutants barely reactive with NEM were clustered from Arg-71 to Ser-91, a region which corresponds to the putative transmembrane helix III. Several isolated barely reactive positions were presented in the aqueous phase-exposed regions, whereas there was no reactive positions in the transmembrane regions. The majority of the mutants retained transport activity. Only six mutants showed loss of or greatly reduced activity. Two NEM-sensitive hot spots were found in the water-exposed regions.

Cysteine-scanning mutants of lac permease were extensively studied by Kaback and his co-workers (14-22). The important points revealed from their studies are: 1) there are very few essential residues present in the permease, 2) NEM inactivates the transport activity of a few of these cysteine-scanning mutants, and 3) NEM-sensitive positions lie on one face of a putative transmembrane helix. Yan and Maloney (23) also reported that some cysteine mutants in the putative transmembrane segments of G6P/Pi antiporter (UhpT) are sensitive to SH reagents. Their results suggest that water-filled channels, which may contribute to a substrate translocation pathway, are present in the permeases. However, it should be noted that the cysteine mutants insensitive to SH reagents may reflect two completely different situations; 1) the residue is not reactive with SH reagents, or 2) the residue is reactive but the modification does not affect the protein function. In fact, Sahin-Toth and Kaback (14) observed that the rate of inactivation of the activity of the V315C mutant of lac permease by NEM was greatly stimulated in the presence of TDG due to the substrate-induced conformational change, reflecting the change in the reactivity. Therefore, it is required to directly determine the reactivity of each cysteine mutant with NEM to determine the hydrophobicity of the regions flanking each position. In a previous study, we established the cysteine-scanning mutants of the putative helix IX of Tet(B) and its flanking regions, and the NEM binding was directly investigated (26). All of the mutants of the putative transmembrane helix IX were barely reactive with NEM while the mutants of the flanking hydrophilic loop regions were highly reactive (26). The results in this study support the hypothesis that the situations are the same around helix III. It is not known why the periodical appearance of moderately reactive positions corresponding to the water-filled channel face of the transmembrane helix was not observed in Tet(B). The substrate translocation channel of Tet(B), if it exists, may be more hydrophobic than that of lac permease and UhpT.

    FOOTNOTES

* This work was supported by a Grant-in-aid for Scientific Research from The Ministry of Education of Japan and from The Mitsubishi Foundation and by an Esso Research Grant for Women.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

par To whom correspondence should be addressed.

1 The abbreviations used are: NEM, N-ethylmaleimide; MOPS, 4-morpholinepropanesulfonic acid; MMTS, methyl methanethiosulfonate; [14C]NEM, N-[1-14C]ethylmaleimide.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Levy, S. B. (1992) Antimicrob. Agents Chemother. 36, 695-703[Medline] [Order article via Infotrieve]
  2. McMurry, L., Petrucci, R. E., Jr., and Levy, S. B. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 3974-3977[Abstract]
  3. Kaneko, M., Yamaguchi, A., and Sawai, T. (1985) FEBS Lett. 193, 194-198[CrossRef][Medline] [Order article via Infotrieve]
  4. Yamaguchi, A., Udagawa, T., and Sawai, T. (1990) J. Biol. Chem. 265, 4809-4813[Abstract/Free Full Text]
  5. Hillen, W., and Schollmeier, K. (1983) Nucleic Acids Res. 11, 525-539[Abstract]
  6. Nguyen, T. T., Postle, K., and Bertrand, K. P. (1983) Gene (Amst.) 25, 83-92[CrossRef][Medline] [Order article via Infotrieve]
  7. Henderson, P. J. F. (1990) J. Bioenerg. Biomembr. 22, 525-569[Medline] [Order article via Infotrieve]
  8. Yoshida, H., Bogaki, M., Nakamura, S., Ubukata, K., and Konno, M. (1990) J. Bacteriol. 172, 6942-6949[Medline] [Order article via Infotrieve]
  9. Neyfakh, A. A. (1992) Antimicrob. Agents Chemother. 36, 484-485[Abstract]
  10. Eckert, B., and Beck, C. F. (1989) J. Biol. Chem. 264, 11663-11670[Abstract/Free Full Text]
  11. Henderson, P. J. F., and Maiden, M. C. J. (1990) Philos. Trans. R. Soc. Lond. B Biol. Sci. 326, 391-410[Medline] [Order article via Infotrieve]
  12. Allard, J. D., and Bertrand, K. P. (1992) J. Biol. Chem. 267, 17809-17819[Abstract/Free Full Text]
  13. Kimura, T., Ohnuma, M., Sawai, T., and Yamaguchi, A. (1997) J. Biol. Chem. 272, 580-585[Abstract/Free Full Text]
  14. Sahin-Toth, M., and Kaback, H. R. (1993) Protein Sci. 2, 1024-1033[Abstract/Free Full Text]
  15. Dunten, R. L., Sahin-Toth, M., and Kaback, H. R. (1993) Biochemistry 32, 12644-12650[Medline] [Order article via Infotrieve]
  16. Sahin-Toth, M., Persson, B., Schwieger, J., Cohan, P., and Kaback, H. R. (1994) Protein Sci. 3, 240-247[Abstract/Free Full Text]
  17. Frillingos, S., Sahin-Toth, M., Persson, B., and Kaback, H. R. (1994) Biochemistry 33, 8074-8081[Medline] [Order article via Infotrieve]
  18. Sahin-Toth, M., Frillingos, S., Bibi, E., Gonzalez, A., and Kaback, H. R. (1994) Protein Sci. 3, 2302-2310[Abstract/Free Full Text]
  19. Weitzman, C., and Kaback, R. (1995) Biochemistry 34, 9374-9379[Medline] [Order article via Infotrieve]
  20. Frillingos, S., and Kaback, H. R. (1996) Biochemistry 35, 5333-5338[CrossRef][Medline] [Order article via Infotrieve]
  21. He, M. M., Sun, J., and Kaback, H. R. (1996) Biochemistry 35, 12909-12914[CrossRef][Medline] [Order article via Infotrieve]
  22. Frillingos, S., Sun, J., Gonzalez, A., and Kaback, H. R. (1997) Biochemistry 36, 269-273[CrossRef][Medline] [Order article via Infotrieve]
  23. Yan, R-T., and Maloney, P. C. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5973-5976[Abstract/Free Full Text]
  24. Wu, J., Perrin, D. M., Sigman, D. S., Kaback, H. R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9186-9190[Abstract]
  25. Frillingos, S., Wu, J., Venkatesan, P., and Kaback, H. R. (1997) Biochemistry 36, 6408-6414[CrossRef][Medline] [Order article via Infotrieve]
  26. Kimura, T., Suzuki, M., Sawai, T., and Yamaguchi, A. (1996) Biochemistry 35, 15896-15899[CrossRef][Medline] [Order article via Infotrieve]
  27. Yamaguchi, A., Someya, Y., and Sawai, T. (1992) J. Biol. Chem. 267, 19155-19162[Abstract/Free Full Text]
  28. Seol, W., and Shatkin, J. (1992) Biochemistry 31, 3550-3554[Medline] [Order article via Infotrieve]
  29. Jessen-Marshall, A. E., Paul, N. J., Brooker, R. J. (1995) J. Biol. Chem. 270, 16251-16257[Abstract/Free Full Text]
  30. Yamaguchi, A., Akasaka, T., Ono, N., Someya, Y., Nakatani, M., and Sawai, T. (1992) J. Biol. Chem. 267, 7490-7498[Abstract/Free Full Text]
  31. Yamaguchi, A., Akasaka, T., Kimura, T., Sakai, T., Adachi, Y., and Sawai, T. (1993) Biochemistry 32, 5698-5704[Medline] [Order article via Infotrieve]
  32. Kunkel, T. A. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 488-492[Abstract]
  33. Someya, Y., Niwa, A., Sawai, T., and Yamaguchi, A. (1995) Biochemistry 34, 7-12[Medline] [Order article via Infotrieve]
  34. Kimura, T., Sawai, T., and Yamaguchi, A. (1997) Biochemistry 36, 6941-6946[CrossRef][Medline] [Order article via Infotrieve]
  35. Yamaguchi, A., Adachi, K., and Sawai, T. (1990) FEBS Lett. 265, 17-19[CrossRef][Medline] [Order article via Infotrieve]
  36. Philipson, L., Anderson, P., Olshevsky, U., Weinberg, R., and Baltimore, D. (1978) Cell 13, 189-199[Medline] [Order article via Infotrieve]
  37. Yamaguchi, A., Ono, N., Akasaka, T., Noumi, T., and Sawai, T. (1990) J. Biol. Chem. 265, 15525-15530[Abstract/Free Full Text]
  38. Yamaguchi, A., Inagaki, Y., and Sawai, T. (1995) Biochemistry 34, 11800-11806[Medline] [Order article via Infotrieve]
  39. Someya, Y., and Yamaguchi, A. (1996) Biochemistry 35, 9385-9391[CrossRef][Medline] [Order article via Infotrieve]
  40. Yamaguchi, A., Kimura, T., and Sawai, T. (1994) J. Biochem. (Tokyo) 115, 958-964[Abstract]
  41. Yamaguchi, A., Ono, N., Akasaka, T., and Sawai, T. (1992) FEBS Lett. 307, 229-232[CrossRef][Medline] [Order article via Infotrieve]
  42. Yamaguchi, A., Kimura, T., and Sawai, T. (1993) FEBS Lett. 322, 201-204[CrossRef][Medline] [Order article via Infotrieve]
  43. Kimura, T., Inagaki, Y., Sawai, T., and Yamaguchi, A. (1995) FEBS Lett. 362, 47-49[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.